A Comparative Evaluation of the Single-dose Efficacy of Oral Delafloxacin Versus the Single-dose Efficacy of an Intramuscular Injection of Ceftriaxone in Subjects With Uncomplicated Urogenital Gonorrhea

Trial Profile

A Comparative Evaluation of the Single-dose Efficacy of Oral Delafloxacin Versus the Single-dose Efficacy of an Intramuscular Injection of Ceftriaxone in Subjects With Uncomplicated Urogenital Gonorrhea

Discontinued
Phase of Trial: Phase III

Latest Information Update: 06 May 2016

At a glance

  • Drugs Delafloxacin (Primary) ; Ceftriaxone
  • Indications Gonorrhoea
  • Focus Registrational; Therapeutic Use
  • Acronyms PROCEEDING
  • Sponsors Melinta Therapeutics
  • Most Recent Events

    • 18 Jan 2015 Status changed from active, no longer recruiting to discontinued, as reported by ClinicalTrials.gov
    • 13 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
    • 18 Sep 2014 Planned primary completion date changed from 1 Aug 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top